Oversubscription makes a pro-rata allotment necessary. 100 million injection will allow PRISA to further reduce debt and continue pursuing business growth. The operation, which has once again received strong support from shareholders, opens the door to further refinancing.
[...]
This is an abstract of the document. To keep reading, click here and get access to the original version.